P J Schuler
Overview
Explore the profile of P J Schuler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hoffmann T, Greve J, Laban S, Schuler P
HNO
. 2020 Nov;
69(1):14-16.
PMID: 33170312
No abstract available.
12.
Schuler P, Boehm F, Schild L, Greve J, Hoffmann T
HNO
. 2020 Sep;
69(2):131-139.
PMID: 32910258
Robot-assisted surgery (RAS) has already been approved for several clinical applications in head and neck surgery. In some Anglo-American regions, RAS is currently the common standard for treatment of oropharyngeal...
13.
Kundrat D, Graesslin R, Schoob A, Friedrich D, Scheithauer M, Hoffmann T, et al.
Ann Biomed Eng
. 2020 Aug;
49(2):585-600.
PMID: 32785862
Despite great efforts, transoral robotic laser surgery has not been established clinically. Patient benefits are yet to be proven to accept shortcomings of robotic systems. In particular, laryngeal reachability and...
14.
Jeske S, Schuler P, Doescher J, Theodoraki M, Laban S, Brunner C, et al.
Immun Ageing
. 2020 Feb;
17:3.
PMID: 32082401
Introduction: The number of aging cancer patients has increased continuously and will do so further in the future. The immune system of elderly people experiences critical changes over the time....
15.
Jeske S, Theodoraki M, Boelke E, Laban S, Brunner C, Rotter N, et al.
HNO
. 2020 Jan;
68(2):87-93.
PMID: 31915882
Background: Mesenchymal stromal cells (MSC) are multipotent progenitor cells found in the tumor microenvironment. They have an innate and regulatory immune activity, and they are able to produce immunosuppressive adenosine...
16.
Vahl J, Schuler P, Greve J, Laban S, Knopf A, Hoffmann T
HNO
. 2019 Nov;
67(12):955-976.
PMID: 31720696
Total laryngectomy provides a curative approach for patients with advanced laryngeal and hypopharyngeal cancer without distant metastasis. Especially in stage cT4a disease, laryngectomy is superior to primary radio(chemo)therapy in retrospective...
17.
Doescher J, Schuler P, Greve J, Meyer M, Weissinger S, Hoffmann T, et al.
HNO
. 2019 Oct;
67(12):931-934.
PMID: 31628530
Background: Due to their comparatively low incidence, salivary gland carcinomas have only been the subject of isolated clinical studies in recent years. In addition, surgery with/without adjuvant radiotherapy is considered...
18.
Wigand M, Jeske S, Hahn J, Doescher J, Laban S, Hoffmann T, et al.
HNO
. 2019 Sep;
68(3):177-183.
PMID: 31559466
Physiological aging processes of the immune system are associated with an increased susceptibility to infectious, autoimmune and tumor diseases. In accordance with the general demographic development the number of tumor...
19.
Jeske S, Weissinger S, Veit J, Brunner C, Huber U, Theodoraki M, et al.
Eur Arch Otorhinolaryngol
. 2019 Mar;
276(5):1465-1473.
PMID: 30815724
Purpose: Adenoid cystic carcinoma (ACC) of the head and neck is a rare and highly malignant tumor, characterized by perineural growth and early distant metastases. The composition of immune cells...
20.
Laban S, Doescher J, Busch C, Wollenberg B, Dietz A, Wurdemann N, et al.
HNO
. 2018 Nov;
66(12):880-887.
PMID: 30402813
Background: Immunotherapeutic strategies are becoming increasingly more important for head and neck cancer and numerous clinical trials were presented at the annual meeting of the American Society of Clinical Oncology...